Louis Denis

15.5k total citations · 2 hit papers
98 papers, 5.8k citations indexed

About

Louis Denis is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Louis Denis has authored 98 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Pulmonary and Respiratory Medicine, 36 papers in Oncology and 21 papers in Molecular Biology. Recurrent topics in Louis Denis's work include Prostate Cancer Treatment and Research (44 papers), Prostate Cancer Diagnosis and Treatment (35 papers) and Cancer, Lipids, and Metabolism (12 papers). Louis Denis is often cited by papers focused on Prostate Cancer Treatment and Research (44 papers), Prostate Cancer Diagnosis and Treatment (35 papers) and Cancer, Lipids, and Metabolism (12 papers). Louis Denis collaborates with scholars based in United States, Belgium and Netherlands. Louis Denis's co-authors include Richard Sylvester, Adrian P.M. van der Meijden, C Bouffioux, Karl‐Heinz Kurth, Willem Oosterlinck, J. Alfred Witjes, Donald W. W. Newling, Eric K. Rowinsky, Anthony W. Tolcher and K. Griffiths and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Louis Denis

94 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

2006 2.1k citations Richard Sylvester, Adrian P.M. van der Meijden et al. European Urology profile →
Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignancies

2001 830 citations Chris H. Takimoto, Anthony W. Tolcher et al. profile →

Peers

Countries citing papers authored by Louis Denis

Since Specialization

Citations

This map shows the geographic impact of Louis Denis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis Denis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis Denis more than expected).

Fields of papers citing papers by Louis Denis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louis Denis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis Denis. The network helps show where Louis Denis may publish in the future.

Co-authorship network of co-authors of Louis Denis

This figure shows the co-authorship network connecting the top 25 collaborators of Louis Denis. A scholar is included among the top collaborators of Louis Denis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louis Denis. Louis Denis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oral spleen tyrosine kinase/Janus Kinase inhibitor gusacitinib for the treatment of chronic hand eczema: Results of a randomized phase 2 study 2023 ·Journal of the American Academy of Dermatology ·Pablo A. Jimenez, Howard Sofen, Robert Bissonnette, Mark Lee, Joseph F. Fowler, David J. Zammit, Yusong Chen, Niranjan Rao, Louis Denis, Sandeep Kumar Gupta	25
2	ASN004, A 5T4-targeting scFv-Fc Antibody–Drug Conjugate with High Drug-to-Antibody Ratio, Induces Complete and Durable Tumor Regressions in Preclinical Models 2021 ·Molecular Cancer Therapeutics ·Roger A. Smith, David J. Zammit, Nitin K. Damle, Helen Usansky, Sanjeeva Reddy, Jun-Hsiang Lin, Mahesh Mistry, Niranjan Rao, Louis Denis, (unknown)	19
3	Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis 2019 ·Journal of Allergy and Clinical Immunology ·Ana B. Pavel, Teresa Song, Hyun Je Kim, Ester Del Duca, James G. Krueger, Celina Dubin, Xiangyu Peng, Hui Xu, Ning Zhang, Yeriel Estrada, Louis Denis, Niranjan Rao, (unknown), David J. Zammit, Robert Bissonnette, Emma Guttman‐Yassky	110
4	Translational Education 2017 ·PubMed ·Denis Horgan, Daniel Schneider, Gabriella Pravettoni, Angelo Paradiso, Louis Denis, Christine Chomienne	1
5	ecancermedicalscience 2016 ·ecancermedicalscience ·Louis Denis	0
6	PCA: Prostate Cancer, Patient‐Centred Approach or both? 2012 ·British Journal of Urology ·Louis Denis, Steven Joniau, Alberto Bossi, (unknown), John M. Fitzpatrick	12
7	Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies 2009 ·Cancer Chemotherapy and Pharmacology ·Chia‐Chi Lin, Muralidhar Beeram, Eric K. Rowinsky, Chris H. Takimoto, Chee M. Ng, Charles E. Geyer, Louis Denis, Johann S. de Bono, Desirée Hao, Anthony W. Tolcher, Sun Young Rha, Jacques Jolivet, Amita Patnaik	2
8	First Study of the Safety, Tolerability, and Pharmacokinetics of CP-724,714 in Patients with Advanced Malignant Solid HER2-Expressing Tumors 2007 ·Clinical Cancer Research ·Pamela N. Münster, Carolyn D. Britten, Monica Mita, Karen A. Gelmon, Susan Minton, Stacy L. Moulder, Dennis J. Slamon, Feng Guo, Stephen P. Letrent, Louis Denis, Anthony W. Tolcher	24
9	PD3-1-6: PF-3512676 (CPG 7909), a toll-like receptor 9 agonist-status of development for non-small cell lung cancer (NSCLC) 2007 ·Journal of Thoracic Oncology ·David Readett, Louis Denis, Arthur Μ. Krieg, Rebecca Benner, (unknown)	5
10	The Prevention of Prostate Cancer 2007 ·PubMed ·K. Griffiths, Domenico Prezioso, A. Turkes, Louis Denis	11
11	Review paper Changing concepts on prostatitis 2006 ·Archives of Medical Science ·Domenico Prezioso, Kurt G. Naber, Bernard Lobel, W. Weidner, (unknown), Louis Denis, K. Griffiths	0
12	Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials breakdown → 2006 ·European Urology ·Richard Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck, J. Alfred Witjes, C Bouffioux, Louis Denis, Donald W. W. Newling, Karl‐Heinz Kurth	2101
13	A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors 2005 ·Cancer Chemotherapy and Pharmacology ·Henry C. Pitot, Alex A. Adjei, Joel M. Reid, Jeff A. Sloan, Philip J. Atherton, Joseph Rubin, Steven R. Alberts, Barbara A. Duncan, Louis Denis, Larry J. Schaaf, Donghua Yin, Amarnath Sharma, (unknown), Langdon L. Miller, Charles Erlichman	23
14	An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow‐up 2002 ·Cancer ·Frank A. Vicini, Alvaro A. Martinez, Gerald E. Hanks, A.L. Hanlon, Brian J. Miles, (unknown), (unknown), Haakon Ragde, Jeffrey D. Forman, James Fontanesi, Larry L. Kestin, György Kovács, Louis Denis, Kevin M. Slawin, Peter T. Scardino	42
15	The European randomized study of screening for prostate cancer 1997 ·Cancer ·(unknown), Louis Denis	30
16	The European randomized study of screening for prostate cancer 1997 ·Cancer ·(unknown), Louis Denis	4
17	Planning controlled clinical trials 1997 ·Urology ·Louis Denis, Bo Johan Norlén, Lars Holmberg, Colin B. Begg, (unknown), Timothy J Wilt	5
18	Hormone refractory disease 1995 ·Seminars in Surgical Oncology ·Charles Mahler, Louis Denis	23
19	European randomized study of screening for prostate cancer. Progress report of Antwerp and Rotterdam Pilot studies 1995 ·Cancer ·Fritz H. Schröder, Louis Denis, Wim J. Kirkels, Harry J. de Koning, (unknown)	58
20	Use of ketoconazole in the treatment of a virilizing adrenocortical carcinoma 1989 ·European Journal of Endocrinology ·Johan Verhelst, Patrick Druwé, P. Van Erps, Louis Denis, Charles Mahler	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact